Phase I Trial of Selinexor (KPT-330), A First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) In Patients (pts) With Advanced Acute Myelogenous Leukemia (AML) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Savona, Michael
  • Garzon, Ramiro
  • Brown, Peter de Nully
  • Yee, Karen
  • Lancet, Jeffrey E
  • Gutierrez, Martin
  • Gabrail, Nashat
  • Mau-Sorensen, Morten
  • Baz, Rachid
  • Byrd, John C
  • Kuruvilla, John
  • Siegel, David S
  • Shacham, Sharon
  • Rashal, Tami
  • Yau, Cindy YF
  • McCauley, Dilara
  • Saint-Martin, Jean-Richard
  • McCartney, John
  • Landesman, Yosef
  • Klebanov, Boris
  • Pond, Gregory
  • Oza, Amit M
  • Kauffman, Michael
  • Mirza, Mansoor R
  • Stone, Richard M

publication date

  • November 15, 2013

published in